Focusing effects of L-dopa in Parkinson's disease

Human Brain Mapping

Volumn 31, Issue 1, 2010, Pages 88-97

  Ng, Bernard ^a   Palmer, Samantha ^a   Abugharbieh, Rafeef ^a,b   McKeown, Martin J ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

3D moment invariants; fMRI; Modeling; Region of interest (ROI); Spatial analysis

Indexed keywords

BROMOCRIPTINE; DOMPERIDONE; LEVODOPA; ROPINIROLE; TRIHEXYPHENIDYL;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMISPHERE; HUMAN; MALE; MOTOR CORTEX; OXYGEN BLOOD LEVEL; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE; VISUOMOTOR COORDINATION;

AGED; ANTIPARKINSON AGENTS; BRAIN; BRAIN MAPPING; CEREBELLUM; CEREBROVASCULAR CIRCULATION; DISABILITY EVALUATION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LEVODOPA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOTOR CORTEX; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREFRONTAL CORTEX; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

EID: 74049128966     PISSN: 10659471     EISSN: None     Source Type: Journal    
DOI: 10.1002/hbm.20847     Document Type: Article

References (33)

1. Bosnell R, Wegner C, Kincses ZT, Korteweg T, Agosta F, Ciccarelli O, De Stefano N, Gass A, Hirsch J, Johansen-Berg H, Kappos L, Barkhof F, Mancini L, Manfredonia F, Marino S, Miller DH, Montalban X, Palace J, Rocca M, Enzinger C, Ropele S, Rovira A, Smith S, Thompson A, Thornton J, Yousry T, Whitcher B, Filippi M, Matthews PM (2008): Reproducibility of fMRI in the clinical setting: Implications for trial designs. Neuroimage 42: 603-610.
2. Brainard DH (1997): The psychophysics toolbox. Spat Vis 10: 433-436.
3. Buhmann C, Glauche V, Stürenburg HJ, Oechsner M, Weiller C, Büchel C (2003): Pharmacologically modulated fMRI-Cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 126: 451-461.
4. Castanon AN, Ghosh SS, Tourville JA, Guenther FH (2003): Region-of-interest based analysis of functional imaging data. NeuroImage 19: 1303-1316.
5. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM (2002): Dopaminergic modulation of high-level cognition in parkinson's disease: The role of the prefrontal cortex revealed by PET. Brain 125: 584-594.
6. Dickson JM, Grünewald RA (2004): Somatic symptom progression in idiopathic Parkinson's disease. Parkinsonism Relat Disord 10: 487-492.
7. Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, Chaly T, Robeson W, Margouleff D, Przedborski S, Fahn S (1994): The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14: 783-801.
8. Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, Spetsieris P, Alterman R, Kelly PJ, Dogali M, Fazzini E, Beric A (1997): Metabolic correlates of pallidal neuronal activity in Parkinson's disease. Brain 120: 1315-1324.
9. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ, Moeller JR, Eidelberg D (2001): Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57:2083-2088.
10. Goodall C (1991): Procrustes methods in the statistical analysis of shape. J R Statist Soc B 53: 285-339.
11. Haslinger B, Erhard P, Kämpfe N, Boecker H, Rummeny E, Schwaiger M, Conrad B, Ceballos-Baumann AO (2001): Eventrelated functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 124 (Part 3):558-570.
12. Hoehn MM, Yahr MD (1967): Parkinsonism: Onset, progression and mortality. Neurology 17: 427-442.
13. Karni A, Meyer G, Jezzard P, Adams MM, Turner R, Ungerleider LG (1995): Functional MRI evidence for adult motor cortex plasticity during motor skill learning. Nature 377: 155-158.
14. Li SC, Sikström S (2002): Integrative neurocomputational perspectives on cognitive aging, neuromodulation, and representation. Neurosci Biobehav Rev 26: 795-808.
15. Liao R, Krolik JL, McKeown MJ (2005): An information-theoretic criterion for intrasubject alignment of FMRI time series: Motion corrected independent component analysis. IEEE Trans Med Imaging 24: 29-44.
16. Liu GT, Miki A, Goldsmith Z, van Erp TG, Francis E, Quinn GE, Modestino EJ, Bonhomme GR, Haselgrove JC (2002): Eye dominance in the visual cortex using functional MRI at 1.5 T: An alternative method. J AAPOS 6: 40-48.
17. Mattay VS, Tessitore A, Callicott JH, Bertolino A, Goldberg TE, Chase TN, Hyde TM, Weinberger DR (2002): Dopaminergic modulation of cortical function in patients with parkinson's disease. Ann Neurol 51: 156-164.
18. Marshall I, Simonotto E, Deary IJ, Maclullich A, Ebmeier KP, Rose EJ, Wardlaw JM, Goddard N, Chappell FM (2004): Repeatability of motor and working-memory tasks in healthy older volunteers: Assessment at functional MR Imaging. Radiology 233: 868-877.
19. McKeown MJ (2000): Detection of consistently task-related activations in fMRI data with hybrid independent component analysis (HYBICA). NeuroImage 11: 24-35.
20. Mehta M, Owen AM, Sahakian BJ, Mavaddat N, Pickard JD, Robbins TW (2000): Ritalin and working memory modulation in humans: Ritalin enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain. J Neurosci 20: RC1-RC6.
21. Monchi O, Petrides M, Doyon J, Postuma RB, Worsley K, Dagher A (2004): The neural bases of set-shifting deficits in parkinsons disease. J Neurosci 24: 702-710.
22. Ng B, Abugharbieh R, Huang X, McKeown MJ (2006): Characterizing fMRI activations within regions of interest (ROIs) using 3D moment invariants. In Proc of IEEE Workshop on Mathematical Methods in Biomedical Image Analysis, New York, NY.
23. Ng B, Abugharbieh R, Huang X, McKeown MJ (2009): Spatial characterization of fMRI activation maps using invariant 3D moment descriptors. IEEE Trans Med Imaging 28: 261-268.
24. Playford ED, Jenkins IH, Passingham RE, Nutt J, Frackowiak RS, Brooks DJ (1992): Impaired mesial frontal and putamen activation in Parkinson's disease: A positron emission tomography study. Ann Neurol 32: 151-161.
25. Rorden C, Brett M (2000): Stereotaxic display of brain lesions. Behav Neurol 12: 191-200.
26. Rougemont D, Baron JC, Collard P, Bustany P, Comar D, Agid Y (1984): Local cerebral glucose utilisation in treated and untreated patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 47: 824-830.
27. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, Bozzao L, Berry I, Montastruc JL, Chollet F, Rascol O (2000): Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study. Brain 123: 394-403.
28. Sikstrom S (2007): Computational perspectives on neuromodulation of aging. Acta Neurochir Suppl 97 (Part 2):513-518.
29. Strafella AP, Ko JH, Grant J, Fraraccio M, Monchi O (2005): Corticostriatal functional interactions in Parkinson's disease: A rTMS/ [11C]raclopride PET study. Eur J Neurosci 22: 2946-2952.
30. Talairach J, Tournoux M (1988): Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers.
31. Thickbroom GW, Phillips BA, Morris I, Byrnes ML, Mastaglia FL (1998): Isomteric force-related activity in sensorimotor cortex measured with functional MRI. Exp Brain Res 121: 59-64.
32. Turner RS, Grafton ST, McIntosh AR, DeLong MR, Hoffman JM (2003): The functional anatomy of parkinsonian bradykinesia. Neuroimage 19: 163-179.
33. Winterer G, Musso F, Vucurevic G, Stoeter P, Konrad A, Seker B, Gallinat J, Dahmen N, Weinberger DR (2006): COMT genotype predicts BOLD signal and noise characteristics in prefrontal circuits. Neuroimage 32: 1722-1732.